Low thyroid signaling raises prolactin.

The relationship between thyroid function and prolactin regulation is a well-established physiological pathway. Clinical and mechanistic evidence confirms that low thyroid signaling acts as a primary driver for elevated prolactin levels through hypothalamic-pituitary signaling.

Clinical effectiveness and prevalence

Research consistently demonstrates a strong correlation between hypothyroidism and hyperprolactinemia.

• Prevalence rates: In populations with primary hypothyroidism, the prevalence of hyperprolactinemia ranges from approximately 13% to over 40%, depending on the severity of the thyroid deficiency.
• Correlation with TSH: Clinical data show a positive correlation between thyrotropin-stimulating hormone (TSH) and prolactin levels, particularly in primary and subclinical hypothyroidism.
• Treatment response: The mechanistic link is validated by the fact that thyroid hormone replacement therapy (levothyroxine) typically resolves hyperprolactinemia in roughly 70% of cases, confirming that the prolactin elevation is secondary to thyroid status.

Mechanistic explanations

The biological basis for this elevation resides in the dual stimulatory role of thyrotropin-releasing hormone (TRH) and the loss of negative feedback loops.

• Loss of feedback: In primary hypothyroidism, the lack of circulating thyroid hormones (T3 and T4) fails to inhibit the hypothalamus. This leads to a compensatory surge in TRH production.
• Dual stimulation: While TRH primarily targets thyrotrophs to release TSH, it also serves as a potent secretagogue for pituitary lactotrophs.
• Intracellular signaling: TRH binds to G-protein-coupled receptors on lactotrophs, activating the phospholipase C (PLC) pathway. This generates inositol trisphosphate (IP3), which triggers the release of intracellular calcium—the critical signal for prolactin exocytosis.
• Transcriptional regulation: Beyond immediate release, chronic TRH elevation upregulates prolactin mRNA and modulates microRNAs that normally suppress prolactin synthesis, leading to increased production and, in severe cases, lactotroph hyperplasia.

Bottom line

Low thyroid signaling leads to elevated TRH, which directly stimulates pituitary lactotrophs to release prolactin. This is a clinically significant cause of secondary hyperprolactinemia that usually resolves with adequate thyroid hormone replacement.